http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2518965-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c9303a2c93645d26a1c84fb810ca0bd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d14671c1f63d0b933a2bec380021c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb143caa9305a3b3c6401ebdf1d79f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1368894d614f25f5c13a813da2f26011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3508ad57c0588cfb8cacd42bbac99e22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_493eee88ac835c2761af5cef08294b2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dcf6806f8ab71b3060e28aac925ff7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35018f3fcb633c7a8719a7ce6602891f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c382ea56b4e176e628ff281a2fce746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f4d438c2cdf324f162d8eeaee4005e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ec73d96fdb22c6bf761f3993b79163
publicationDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2518965-C1
titleOfInvention Method of pharmacological correction of ischemia of skeletal muscle with resveratrol
abstract FIELD: veterinary medicine. n SUBSTANCE: for correction of skeletal muscle ischemia in rats with ischemia of lower leg muscles, modelled on the second day of the experiment, resveratrol is intragastrically administered in a daily dose of 2.0 mg/kg every 46 hours of the first 7 days of the experiment. The microcirculation level in the muscle of lower leg was evaluated on the 28 th day of induction of ischemia. n EFFECT: effective treatment of skeletal muscle ischemia in the experiment due to stimulation of neoangiogenesis. n 1 ex, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2734158-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2559937-C1
priorityDate 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2438192-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2432618-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4888856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2438188-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273

Total number of triples: 32.